Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy

about

Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy

Item

http://www.wikidata.org/entity/Q36881967

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Evaluating the Role of Cellula ...... ing Protease Inhibitor Therapy

@en

type

Item

label

Evaluating the Role of Cellula ...... ing Protease Inhibitor Therapy

@en

prefLabel

Evaluating the Role of Cellula ...... ing Protease Inhibitor Therapy

@en

P1476

Evaluating the Role of Cellula ...... ing Protease Inhibitor Therapy

@en

P2093

Ashley Ulm

http://www.w3.org/2001/XMLSchema#string

Hong Ji

http://www.w3.org/2001/XMLSchema#string

Kenneth E Sherman

http://www.w3.org/2001/XMLSchema#string

Nadeem Anwar

http://www.w3.org/2001/XMLSchema#string

Susan D Rouster

http://www.w3.org/2001/XMLSchema#string

P2860

Boceprevir for previously treated chronic HCV genotype 1 infection

Relation between viral fitness and immune escape within the hepatitis C virus protease

CD8 Epitope Escape and Reversion in Acute HCV Infection

Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease

Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire

The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes

A community resource benchmarking predictions of peptide binding to MHC-I molecules.

Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin

Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.

Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus

P304

252-258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/VIM.2015.0093

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mohamed T Shata

Helal F Hetta

Enass A Abdel-Hameed

P577

2016-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294918312

http://www.w3.org/2001/XMLSchema#string

P698

26885675

http://www.w3.org/2001/XMLSchema#string

P932

4860622

http://www.w3.org/2001/XMLSchema#string